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IMPORTANCE Low breast cancer survival in sub-Saharan Africa’s young population increases
the likelihood that breast cancer deaths result in maternal orphans, ie, children (<18 years)
losing their mother.
OBJECTIVE To estimate the number of maternal orphans and their ages for every 100 breast
cancer deaths in sub-Saharan African settings during 2014-2019 and to describe family
concerns about the orphaned children.
DESIGN, SETTING, AND PARTICIPANTS Deaths occurring between September 1, 2014,
and July 1, 2019, in the African Breast Cancer–Disparities in Outcomes (ABC-DO) were
examined in a cohort of women diagnosed with breast cancer during 2014-2017 at major
cancer treatment hospitals in Namibia, Nigeria, Uganda, and Zambia. The cohort was actively
followed up for vital status via a trimonthly mobile phone call to each woman or her next
of kin (typically a partner, husband, or child).
MAIN OUTCOMES AND MEASURES The number (Poisson counts) and ages of new orphans
at the time of maternal death.
RESULTS This cohort study found that a total of 795 deaths resulted in 964 new maternal
orphans, with deaths occurring in women younger than 50 years accounting for 85%
of the orphans. For every 100 deaths in women younger than 50 years, there were 210 new
orphans (95% CI, 196-225) overall, with country-specific estimates of 189 in Nigerian, 180 in
Namibian, 222 in Ugandan, and 247 in Zambian Black women. For every 100 deaths of the
women at any age, there were 121 maternal orphans, 17% of whom were younger than 5
years, 32% aged 5 to 9 years, and 51% aged 10 to 17 years at the time of maternal death.
In follow-up interviews, families’ concerns for children’s education and childcare were
reported to be exacerbated by the financial expenses associated with cancer treatment.
CONCLUSIONS AND RELEVANCE This study provides evidence that the number of maternal
orphans due to breast cancer exceeds the number of breast cancer deaths among women in
sub-Saharan Africa. The intergenerational consequences associated with cancer deaths in
sub-Saharan Africa appear to be large and support the need for continued action to improve
survival.
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I n sub-Saharan Africa, where cancer survival is relativelylow,1 families affected by cancer are more likely to experi-ence a death than in other world regions. With sub-
Saharan Africa’s young population and high fertility rates,2 the
deaths of middle-aged mothers and fathers result in mater-
nal and paternal orphans (children <18 years at parental death).
Breast cancer accounts for 24% of cancer deaths in sub-
Saharan African women.3 Although half (48%) of these deaths
occur in women younger than 50 years (eFigure in the Supple-
ment), we are not aware of quantifications of the resulting ma-
ternal orphans. In the present study, we examined these num-
bers in the African Breast Cancer–Disparities in Outcomes
(ABC-DO) cohort4,5 and highlight the outcomes of the deaths
in families.
Methods
Study Design and Participants
The ABC-DO study evaluates a hospital-based breast cancer co-
hort in sub-Saharan Africa to estimate overall survival and its
determinants; the protocol has been published,4 and ethics ap-
proval was obtained from all national or institutional review
boards (eAppendix in the Supplement). This study followed
the Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) reporting guideline. Participating
hospitals included in this analysis were the only public cancer
treatment hospitals in Namibia, Uganda, and Zambia, located
in their capital cities, and 2 hospitals and a clinic in Nigeria’s
Imo and Abia states. All women aged 18 years or older with
incident histologically or clinically diagnosed breast cancer
between September 1, 2014, and December 31, 2017, were
invited to participate, of whom 99% provided written informed
consent (stating that published information would not identify
women). Participants did not receive financial compensation.
Women were included regardless of cancer stage, intention to
undergo treatment, or residential location. The baseline
interview included information on the woman’s age, number
of children and the woman’s age at the first and last live births,
self-reported HIV status, and because these factors differ by
race, self-assigned ethnicity in Namibia where Black ethnicities
were combined and White and mixed-race women were
grouped into a non-Black women category.
The cohort was actively followed up for vital status via a
trimonthly mobile phone call to each woman or her next of kin
(typically a partner, husband, or child), an approach that mini-
mized losses to follow-up.6 When the next of kin reported a
death (91% of deaths), they were asked how the death af-
fected the family, and free-text responses were classified into
emotional consequences, financial concerns, and other con-
cerns related to children. In the present analysis, we esti-
mated the number of maternal orphans associated with deaths
occurring until July 1, 2019 (median, 3.5 years [interquartile
range, 2.9-4.2 years] after recruitment had women survived).
Statistical Analysis
To estimate the number of maternal orphans, we first calcu-
lated the ages of the woman’s children from the first and last
live births at the date of her death (eMethods and eTable 1in
the Supplement). The ages of children from any middle live
births were assumed with equal spacing between the first and
last child. Children’s ages were used to calculate the number
of each woman’s maternal orphans at her death. Thereafter,
because children of all live births were not necessarily still alive,
if a woman indicated at her most recent contact that fewer chil-
dren lived with her, the number of maternal orphans was re-
duced to this lower number. Determinants of the number of
orphans were modeled using Poisson regression models, and
Wald tests were used to obtain P values for linear trends in edu-
cation and for differences by residence and HIV status. Sig-
nificance was determined using 2-sided tests with a 5% thresh-
old. Statistical analysis was conducted using Stata, version 15
(StataCorp LLC). Further statistical details are provided in the
eMethods in the Supplement.
Results
Of the 1541 cohort members, mean (SD) age at diagnosis was
50.4 (14.3) years, and 149 women (10%) were HIV-positive.
Breast cancer diagnoses in women with data available were
stages I/II in 523 (36%), stage III in 688 (48%), and stage IV in
225 (16%) women. Three-year survival was 50%, and pub-
lished determinants of survival include late stage, treatment
gaps, young age (<30 years), low educational level, positive HIV
status, and triple-negative tumors.5 In total, 795 women had
died by July 1, 2019: 256 Nigerian women, 249 Ugandan
women, 185 Namibian Black women, 86 Zambian women, and
19 Namibian non-Black women (eTable 2 in the Supplement).
A total of 390 of the 795 deaths (49%) occurred in women
younger than 50 years. A total of 711 women (89%) who died
had been parous (country range, 81%-94%) (eTable 2 in the
Supplement). Among those older than 40 years when they
died, mean (SD) age at the last birth ranged from 34 (5.9) years
in the more recent to 39 (7.1) years in the earlier birth cohort,
ie, giving rise to offspring who may still be minors if the mother
died in or before her 50s. The median number of live births was
3 to 4 in Namibia and Nigeria and between 4 and 7 in Uganda
and Zambia, but was lower in women who died when they were
Key Points
Question How many maternal orphans resulted from every 100
breast cancer deaths in sub-Saharan African settings in
2014-2019?
Findings In the African Breast Cancer–Disparities in Outcomes
cohort study of women with breast cancer, there were 964
children (<18 years) remaining at the time of maternal death and
795 deaths of women in Namibia, Nigeria, Uganda, and Zambia.
Half of these maternal deaths occurred in women younger than
50 years and, for every 100 breast cancer deaths in this age group,
210 children became maternal orphans.
Meaning The results of this study quantify the intergenerational
consequences associated with cancer death among children in
Sub-Saharan Africa whose mothers die from breast cancer.
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younger than 40 years owing to their shortened reproductive
life span. Namibian non-Black women had lower parity (me-
dian, 2 live births) (eTable 3 in the Supplement).
These 795 deaths resulted in 964 new maternal orphans,
ie, 121 maternal orphans per 100 deaths, ranging from 96
(95% CI, 83-111) in Namibian Black women to 145 (95% CI, 131-
161) in Ugandan women (Table 1). Deaths in women younger
than 50 years resulted in 819 maternal orphans (85%). At these
ages there were 210 (95% CI, 196-225) orphans per 100 breast
cancer deaths overall, with the highest estimates in Uganda
(222) and Zambia (247), followed by 189 in Nigeria and 180 in
Namibia (Figure). Most (494) orphans (51%) were older than
10 years at their mothers’ death, 311 (32%) were aged 5 to 9
years, and 160 (17%) were younger than 5 years. Deaths of
women from lower educational level groups and from rural
areas (186; 95% CI, 170-203) were associated with more or-
phans, whereas, owing to their lower parity, deaths of HIV-
positive women (122; 95% CI, 99-150) resulted in 33% fewer
orphans than of HIV-negative women (175; 95% CI, 163-187)
(Table 2).
The next of kin’s reports of how the woman’s death af-
fected the family highlighted emotional and financial results
(eTable 4 in the Supplement). Concerns for children and their
education and care were also common. Financial worries were
exacerbated by a lack of assets to pay for cancer treatment.
Grandparents were mentioned as stepping in to provide child-
Table 1. Deaths and Resulting Maternal Orphans Among Women in the ABC-DO Study, 2014-2019,
by Country and Age at Deatha
Country
Age at breast cancer death, y
<40 40-49 50-59 ≥60 All ages
Deaths, No. (%)
All 169 (21) 221 (28) 187 (24) 218 (27) 795 (100)
Namibia (Black) 27 (15) 44 (24) 42 (23) 72 (39) 185 (100)
Namibia (non-Black) 1 (5) 4 (21) 5 (26) 9 (47) 19 (100)a
Nigeria 61 (24) 71 (28) 62 (24) 62 (24) 256 (100)
Uganda 61 (25) 83 (33) 61 (25) 44 (18) 249 (100)
Zambia 19 (22) 19 (22) 17 (20) 31 (36) 86 (100)
Women who died leaving minor children, No. (%)
All 128 (74) 174 (79) 77 (41) 4 (2) 383 (48)
Namibia (Black) 20 (74) 38 (86) 16 (38) 1 (1) 75 (41)
Nigeria 37 (61) 52 (73) 23 (37) 2 (3) 114 (45)
Uganda 54 (89) 65 (78) 28 (46) 0 (0) 147 (59)
Zambia 16 (84) 18 (95) 9 (53) 1 (3) 44 (48)
Maternal orphans, No. (%)
All 354 (37) 465 (48) 141 (15) 4 (0.4) 964 (100)
Namibia (Black) 56 (31) 91 (51) 30 (17) 1 (0.6) 178 (100)
Nigeria 102 (34) 148 (49) 47 (16) 2 (0.7) 299 (100)
Uganda 150 (41) 169 (47) 43 (12) 0 (0) 362 (100)
Zambia 43 (37) 51 (44) 20 (17) 1 (0.9) 115 (100)
Maternal orphans <18 y per 100 breast cancer deaths, No. (95% CI)
All 209 (188-232) 210 (192-230) 75 (63-89) 2 (0-5) 121 (114-129)
Namibia (Black) 207 (157-269) 207 (167-254) 71 (48-102) 1 (0-8) 96 (83-111)
Nigeria 167 (136-203) 208 (176-245) 76 (56-101) 3 (0-12) 117 (104-131)
Uganda 246 (208-289) 204 (174-237) 70 (51-95) 0 (0-8) 145 (131-161)
Zambia 226 (164-305) 268 (200-353) 118 (72-182) 3 (0-18) 134 (110-161)
No. of maternal orphans <10 y per 100 breast cancer deaths (95% CI)
All 148 (130-167) 92 (80-105) 10 (6-16) 0 (0-2) 59 (54-65)
Namibia (Black) 152 (109-206) 82 (57-113) 14 (5-31) 0 (0-5) 45 (36-56)
Nigeria 134 (107-167) 99 (77-125) 10 (4-21) 0 (0-6) 62 (52-72)
Uganda 161 (130-196) 86 (67-108) 3 (0-12) 0 (0-8) 69 (59-80)
Zambia 137 (89-201) 121 (77-182) 29 (10-69) 0 (0-12) 63 (47-82)
No. of maternal orphans <5 y per 100 breast cancer deaths (95% CI)
All 67 (56-81) 20 (15-27) 1 (0-4) 0 (0-2) 20 (17-24)
Namibia (Black) 67 (40-105) 16 (6-33) 2 (0-13) 0 (0-5) 14 (9-21)
Nigeria 69 (50-93) 21 (12-35) 0 (0-6) 0 (0-6) 22 (17-29)
Uganda 66 (47-89) 19 (11-31) 0 (0-6) 0 (0-8) 22 (17-29)
Zambia 63 (33-110) 32 (12-69) 6 (0-33) 0 (0-12) 22 (13-35)
Abbreviation: ABC-DO, African Breast
Cancer–Disparities in Outcomes.
a There were 10 maternal orphans
associated with the 19 breast cancer
deaths in non-Black Namibian
women. These are not shown for
site-specific strata in the remainder
of the table owing to small numbers
and identifiability, but were
included in the estimates of number
of orphans per 100 deaths for all
sites combined. Thus, the
numerators/denominators differ
for some factors.
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care. Typically, hardships often clustered, as illustrated in this
quotation: “She left a younger child of 2 years with no help
yet most of the land was sold in order to buy the prescribed
drugs for her treatment.”
Discussion
More than half a million breast cancer deaths are projected to
occur in sub-Saharan African during 2020-2029.7 This analy-
sis suggests that at least as many new maternal orphans will
result from these deaths, ie, highlighting the intergenera-
tional effects of cancer unique to young populations with low
survival. The number of maternal orphans was associated with
maternal deaths in women younger than 50 years, and owing
to higher fertility levels, particularly affected HIV-negative
women and women in rural communities. Lower socioeco-
nomic groups, which have lower breast cancer survival,5 re-
sult in more maternal orphans, thus propagating a cycle of dis-
advantage.
Limitations
Our estimates of maternal orphans are based on a large num-
ber of patients attending major cancer treatment centers in 4
countries and, to our knowledge, are the only available esti-
mates at present. However, because ABC-DO was not de-
signed a priori to address the number of maternal orphans, fu-
ture studies of this issue can be improved by including
population-based cases and noncapital settings, by directly
ascertaining the numbers and ages of children and the famil-
ial care situation. Although ABC-DO deaths occurred within
4 years of diagnosis, standardization to the Globocan 2018 age
at death distribution did not materially affect the results
(eTable 5 in the Supplement).The ABC-DO findings indicated
a high percentage of unmarried women; we did not have in-
formation on other partner/adult support and caregivers. Stud-
ies with prospective follow-up of children’s development
and care should also be undertaken.
Conclusions
To minimize the intergenerational effects of breast cancer
deaths in sub-Saharan Africa, preventing breast cancer
Figure. Country-Specific and Overall Number of Maternal Orphans
Resulting From Every 100 Breast Cancer Deaths
Maternal orphans per 100 breast cancer deaths, No.
Maternal deaths at all agesA
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Table 2. Mean Number of New Maternal Orphans Resulting From 100 Breast Cancer Deaths in Women Younger Than 60 Years
Variable
New maternal orphans per 100 breast cancer deaths in women aged <60 y, No. Ratio
Namibia Black Nigeria Uganda Zambia All Adjusteda Adjustedb
No. deaths 113 194 205 55 567
No. of orphans 157 (134-181) 153 (136-172) 177 (159-196) 207 (171-249) 168 (157-179) NA NA
Education
None/primary 175 (141-213) 126 (92-170) 179 (155-206) 236 (180-304) 176 (159-195) 1.42 (1.16-1.75) 1.30 (1.05-1.61)
Secondary 145 (112-183) 173 (146-203) 181 (153-213) 187 (135-252) 171 (155-189) 1.19 (0.98-1.44) 1.16 (0.96-1.41)
Technical/university 118 (62-202) 143 (117-172) 138 (86-208) 171 (89-299) 141 (120-165) 1 [Reference] 1 [Reference]
P value for trend .11 .92 .47 .19 .13
Residential area
Urban 146 (119-178) 140 (121-162) 127 (97-163) 219 (174-273) 149 (136-164) 1 [Reference] 1 [Reference]
Rural 173 (136-216) 182 (149-219) 192 (171-215) 184 (128-256) 186 (170-203) 1.32 (1.15-1.52) 1.25 (1.08-1.45)
P value .24 .08 .004 .73 .002
HIV
Negative/unknown 169 (143-198) 154 (137-173) 189 (169-210) 224 (179-277) 175 (163-187) 1 [Reference] 1 [Reference]
Positive 113 (74-164) 117 (47-240) 1037 (70-148) 116 (114-245) 122 (99-150) 0.65 (0.53-0.81) 0.67 (0.54-0.84)
P value .05 .47 .002 .21 .003
Abbreviation: NA, not applicable.
a Adjusted for country and age at death.
b Adjusted for country, age at death, educational level, HIV status, and rural residence.
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deaths through early diagnosis and improved timely treat-
ment should form an essential part of every cancer control
plan.8-10 In parallel, support mechanisms are needed for
affected families because maternal deaths impact the chil-
dren’s education,11 development, nutrition, and mortality,12
as described in a joint report by the United Nations Pro-
gramme on HIV/AIDS, the United Nations Children’s Fund,
and the US Agency for International Development.13 Because
women are the cornerstone of many African families, there
is often great upheaval after their death. If the father remar-
ries, children usually remain with their father; otherwise,
they may be cared for by close relatives or in care homes. In
sub-Saharan Africa, lessons can be borrowed from those
gained during the HIV epidemic, such as leaving memories
(eg, photographs of the parents) for children and of models
of care.14 Cancer support associations also play important
roles in relieving pressures on families, and some cancer
associations support the costs of education for orphans.15
ARTICLE INFORMATION
Accepted for Publication: September 29, 2020.
Published Online: December 23, 2020.
doi:10.1001/jamaoncol.2020.6583
Open Access: This is an open access article
distributed under the terms of the CC-BY License.
© 2020 Galukande M et al. JAMA Oncology.
Author Affiliations: Department of Surgery,
College of Health Sciences, Makerere University,
Kampala, Uganda (Galukande); Branch of
Environment and Lifestyle Epidemiology,
International Agency for Research on Cancer, Lyon,
France (Schüz); Fred Hutchinson Cancer Research
Center and University of Washington, Seattle
(Anderson); Windhoek Central Hospital, Namibia
(Zietsman); Department of Surgery, Abia State
University Teaching Hospital Nigeria, Aba, Abia,
Nigeria (Adisa); Breast Oncology Unit, Federal
Medical Centre Owerri, Nigeria (Anele); UNC
Department of Obstetrics and Gynecology,
University of Zambia, Lusaka, Zambia (Parham);
Department of Obstetrics and Gynecology,
University of Washington, Seattle (Pinder);
Outpatient Department, Matero Level One
Hospital, Lusaka, Zambia (Mutumba); Department
of Oncology, Cancer Diseases Hospital, Lusaka,
Zambia (Lombe); Susan G. Komen, Dallas, Texas
(Cabanes); Branch of Environment and Lifestyle
Epidemiology, International Agency for Research on
Cancer, Lyon, France (Foerster, McCormack);
Department of Non-Communicable Diseases
Epidemiology, London School of Hygiene and
Tropical Medicine, London, United Kingdom
(dos-Santos-Silva).
Author Contributions: Dr McCormack had full
access to all the data in the study and takes
responsibility for the integrity of the data and the
accuracy of the data analysis.
Concept and design: Galukande, Schüz, Anderson,
Adisa, Pinder, Songiso, dos-Santos-Silva,
McCormack.
Acquisition, analysis, or interpretation of data:
Galukande, Zietsman, Adisa, Anele, Parham, Pinder,
Lombe, Cabanes, Foerster, dos-Santos-Silva,
McCormack.
Drafting of the manuscript: Galukande, Anderson,
Zietsman, Songiso, McCormack.
Critical revision of the manuscript for important
intellectual content: Galukande, Schüz, Adisa,
Anele, Parham, Pinder, Lombe, Cabanes, Foerster,
dos-Santos-Silva, McCormack.
Statistical analysis: Anele, Foerster, McCormack.




Supervision: Galukande, Adisa, Anele, Pinder,
dos-Santos-Silva.
Conflict of Interest Disclosures: Dr McCormack
reported receiving grants from Susan G. Komen
during the conduct of the study. No other
disclosures were reported.
Funding/Support: Support for the study was
provided by Susan G. Komen grants IIR 13264158,
GSP18IARC001, and GSP19IARC001, NCI
R01CA244559 and the International Agency for
Research on Cancer.
Role of the Funder/Sponsor: The funding
organization had no role in the design and conduct
of the study; collection, management, analysis, and
interpretation of the data; preparation, review, or
approval of the manuscript; and decision to submit
the manuscript for publication.
Disclaimer: Where authors are identified as
personnel of the International Agency for Research
on Cancer/World Health Organization, the authors
alone are responsible for the views expressed in
this article and they do not necessarily represent
the decisions, policy, or views of the International
Agency for Research on Cancer/World Health
Organization.
Additional Contributions: We thank all study
participants and their next of kin for their
participation in the study as well as the team of
study interviewers.
REFERENCES
1. Allemani C, Matsuda T, Di Carlo V, et al;
CONCORD Working Group. Global surveillance of
trends in cancer survival 2000-14 (CONCORD-3):
analysis of individual records for 37 513 025 patients
diagnosed with one of 18 cancers from 322
population-based registries in 71 countries. Lancet.
2018;391(10125):1023-1075. doi:10.1016/S0140-6736
(17)33326-3
2. Moultrie TA, Sayi TS, Timæus IM. Birth intervals,
postponement, and fertility decline in Africa: a new
type of transition? Popul Stud (Camb). 2012;66(3):
241-258. doi:10.1080/00324728.2012.701660
3. Global Cancer Observatory. Accessed June 24,
2020. gco.iarc.fr
4. McKenzie F, Zietsman A, Galukande M, et al.
African Breast Cancer–Disparities in Outcomes
(ABC-DO): protocol of a multicountry mobile health
prospective study of breast cancer survival in
sub-Saharan Africa. BMJ Open. 2016;6(8):e011390.
doi:10.1136/bmjopen-2016-011390
5. McCormack V, McKenzie F, Foerster M, et al.
Breast cancer survival and survival gap
apportionment in sub-Saharan Africa: African
Breast Cancer–Disparities in Outcomes (ABC-DO):
a cohort study. Lancet Glob Health. 2020;8(9):
E1203-E1212. doi:10.1016/S2214-109X(20)30261-8
6. Foerster M, Anele A, Adisa C, et al. Few losses to
follow-up in a sub-Saharan African cancer cohort via
active mobile health follow-up. Am J Epidemiol.
2020;189(10):1185-1196. doi:10.1093/aje/kwaa070
7. Bray F, Soerjomataram I. The changing global
burden of cancer: transitions in human
development and implications for cancer
prevention and control. In: Gelband H, Jha P,
Sankaranarayanan R, Horton S, eds. Cancer: Disease
Control Priorities, Third Edition (Volume 3).
The International Bank for Reconstruction and
Development. Published 2015. Accessed November
17, 2020. https://www.ncbi.nlm.nih.gov/books/
NBK343643/
8. Dvaladze A, Duggan C, Anderson BO. Phased
implementation for breast cancer management in
low-income and middle-income countries:
a proposal for the strategic application of
resource-stratified guidelines by the Breast Health
Global Initiative. Cancer. 2020;126(suppl 10):
2337-2338. doi:10.1002/cncr.32942
9. Ginsburg O, Yip CH, Brooks A, et al. Breast
cancer early detection: a phased approach to
implementation. Cancer. 2020;126(suppl 10):
2379-2393. doi:10.1002/cncr.32887
10. Horton S, Camacho Rodriguez R, Anderson BO,
et al. Health system strengthening: integration of
breast cancer care for improved outcomes. Cancer.
2020;126(suppl 10):2353-2364. doi:10.1002/
cncr.32871
11. Evans DK, Miguel E. Orphans and schooling in
Africa: a longitudinal analysis. Demography. 2007;
44(1):35-57. doi:10.1353/dem.2007.0002
12. Mailhot Vega RB, Balogun OD, Ishaq OF, Bray F,
Ginsburg O, Formenti SC. Estimating child mortality
associated with maternal mortality from breast and
cervical cancer. Cancer. 2019;125(1):109-117. doi:10.
1002/cncr.31780
13. UNAIDS/UNICEF/USAID Collaboration. Children
on the Brink 2004. US Agency for International
Development; 2004.
14. Embleton L, Ayuku D, Kamanda A, et al. Models
of care for orphaned and separated children and
upholding children’s rights: cross-sectional
evidence from western Kenya. BMC Int Health Hum
Rights. 2014;14:9. doi:10.1186/1472-698X-14-9
15. Lalla Salma Foundation. Accessed June 24,
2020. http://www.contrelecancer.ma/en/orphelins-
du-cancer/
The Intergenerational Consequences Associated With Breast Cancer Deaths in Sub-Saharan Africa Brief Report Research
jamaoncology.com (Reprinted) JAMA Oncology Published online December 23, 2020 E5
Downloaded From: https://jamanetwork.com/ on 01/28/2021
